{"parse":{"title":"SCAR-Fc","pageid":35143854,"revid":853098734,"text":{"*":"<div class=\"mw-parser-output\"><table class=\"infobox\" style=\"width:22em\"><tbody><tr><th colspan=\"2\" style=\"text-align:center;font-size:125%;font-weight:bold;background-color: lightblue\">SCAR-Fc</th></tr><tr class=\"noprint\"><td colspan=\"2\" style=\"text-align:center\">\n<div style=\"text-align: right;\">&#91;<a href=\"https://www.wikidata.org/wiki/Q7389070\" class=\"extiw\" title=\"d:Q7389070\">edit on Wikidata</a>]</div></td></tr></tbody></table>\n<p><b>sCAR-Fc</b> (<b>Soluble Receptor Analogue</b>) is an experimental prophylactic treatment against <a href=\"/wiki/Coxsackievirus\" title=\"Coxsackievirus\">coxsackievirus</a> B3 (CVB) infections. Coxsackievirus B3 can cause cardiac damage, eventually resulting in a weakened and enlarged heart that is termed <a href=\"/wiki/Dilated_cardiomyopathy\" title=\"Dilated cardiomyopathy\">dilated cardiomyopathy</a>.<sup id=\"cite_ref-a_1-0\" class=\"reference\"><a href=\"#cite_note-a-1\">&#91;1&#93;</a></sup> While many other treatments inhibit viral proliferation in <a href=\"/wiki/Myocyte\" title=\"Myocyte\">myocytes</a>, sCAR-Fc prevents the virus entering the cell by competitively binding to <a href=\"/wiki/Coxsackie_virus_and_adenovirus_receptor\" title=\"Coxsackie virus and adenovirus receptor\">coxsackie virus and adenovirus receptors</a> (CAR) on the membrane of myocytes.\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Myocarditis\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Myocarditis</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Mechanism\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Mechanism</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Discussion\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Discussion</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#References\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">References</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Myocarditis\">Myocarditis</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=SCAR-Fc&amp;action=edit&amp;section=1\" title=\"Edit section: Myocarditis\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Coxsackievirus B3 is a single-stranded RNA <a href=\"/wiki/Enterovirus\" title=\"Enterovirus\">enterovirus</a> and a member of the <a href=\"/wiki/Picornavirus\" title=\"Picornavirus\"><i>Picornavirdae</i></a> family.<sup id=\"cite_ref-a_1-1\" class=\"reference\"><a href=\"#cite_note-a-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-c_2-0\" class=\"reference\"><a href=\"#cite_note-c-2\">&#91;2&#93;</a></sup> Once the virus penetrates the host's systemic circulation via contaminated water or food, it can travel and infect the heart and cause myocarditis. <a href=\"/wiki/Myocarditis\" title=\"Myocarditis\">Myocarditis</a> is an inflammation of the heart, most commonly cause by viral infections. Amongst the viruses capable of causing myocarditis, CVB3 is a common agent identified in inducing cardiac damage. Internalization of the virus into myocytes occurs by binding to coxsackievirus-adenovirus receptors (CAR) located in <a href=\"/wiki/Tight_junction\" title=\"Tight junction\">tight junctions</a> on cell membranes.<sup id=\"cite_ref-a_1-2\" class=\"reference\"><a href=\"#cite_note-a-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> Once inside the cytoplasm, the virus can use the host's ribosomal machinery to proliferate and replicate progenies for further infection.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> Extensive cardiac <a href=\"/wiki/Necrosis\" title=\"Necrosis\">necrosis</a> can occur by day three after infection as incubated viruses lyse myocytes, resulting in severe and rapid cardiac decompensation. With loss of cardiac cells increasing progressively, infected individual will experience abnormalities in left ventricular systolic and diastolic function, as well as electrical conduction defects manifesting as <a href=\"/wiki/Cardiac_dysrhythmias\" class=\"mw-redirect\" title=\"Cardiac dysrhythmias\">cardiac dysrhythmias</a>.<sup id=\"cite_ref-b_5-0\" class=\"reference\"><a href=\"#cite_note-b-5\">&#91;5&#93;</a></sup> As a result, <a href=\"/wiki/Ejection_fraction\" title=\"Ejection fraction\">ejection fraction</a> decreases substantially.<sup id=\"cite_ref-b_5-1\" class=\"reference\"><a href=\"#cite_note-b-5\">&#91;5&#93;</a></sup> The cytolytic destruction of heart cells can lead to dilated cardiomyopathy if not treated appropriately.\n</p><p>The role of the immune system in response to the presence of a virus  has both beneficial and detrimental effects on the cardiac system.<sup id=\"cite_ref-a_1-3\" class=\"reference\"><a href=\"#cite_note-a-1\">&#91;1&#93;</a></sup> The arrival of <a href=\"/wiki/Natural_killer_cells\" class=\"mw-redirect\" title=\"Natural killer cells\">natural killer cells</a> (NK cells) at the site of infection limits viral proliferation in myocytes. Conversely, while certain cytokines released from immune cells have  protective effects, others such as <a href=\"/wiki/Tumor_necrosis_factor-alpha\" class=\"mw-redirect\" title=\"Tumor necrosis factor-alpha\">tumor necrosis factor-alpha</a> (TNF\u03b1) have deleterious effects on heart cells. Moreover, peak concentrations of <a href=\"/wiki/T_cells\" class=\"mw-redirect\" title=\"T cells\">T cells</a> in the myocardium during days 7-14 play important roles in both viral clearance and immune mediated cardiac damage. T-cells not only lyse and destroy infected myocytes, but due to molecular mimicry, they also destroy normal, healthy cardiac cells, further driving the heart towards dilated cardiomyopathy.<sup id=\"cite_ref-6\" class=\"reference\"><a href=\"#cite_note-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Mechanism\">Mechanism</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=SCAR-Fc&amp;action=edit&amp;section=2\" title=\"Edit section: Mechanism\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>A synthetic and soluble form of CAR (sCAR) has been created to prevent viral infection with CVB3. Attaching Fc domain of <a href=\"/wiki/Immunoglobulin\" class=\"mw-redirect\" title=\"Immunoglobulin\">immunoglobulin</a> <a href=\"/wiki/IgG1\" class=\"mw-redirect\" title=\"IgG1\">IgG1</a> to sCAR (sCAR-Fc) enhances solubility and extends its <a href=\"/wiki/Half-life\" title=\"Half-life\">half-life</a>.<sup id=\"cite_ref-a_1-4\" class=\"reference\"><a href=\"#cite_note-a-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup> Furthermore, once sCAR-Fc binds the virus, <a href=\"/wiki/Macrophages\" class=\"mw-redirect\" title=\"Macrophages\">macrophages</a> and other phagocytic immune cells with Fc receptor recognition bind to the sCAR-Fc-viral complex to eliminate the virus. Essentially, sCAR-Fc mimics CAR receptors on cardiac cells, competitively inhibiting viral attachment and entry into myocytes. Decreased lesions in cardiac tissues, reduced cell necrosis, and diminished inflammatory responses are observed in sCAR-Fc treated cells (CITE). This suggests protective effects against myocardial damage by CVB3.\n</p><p>Conformational changes in a viral particle (A-particle) with sCAR-Fc-virus binding causing the loss of the virus\u2019 internal <a href=\"/wiki/Capsid\" title=\"Capsid\">capsid</a> protein, VP4.<sup id=\"cite_ref-c_2-1\" class=\"reference\"><a href=\"#cite_note-c-2\">&#91;2&#93;</a></sup> This irreversible reaction prevents the virus from interacting with cellular receptors (CAR) on cardiac cells, decreasing infectivity of CVB3.<sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Discussion\">Discussion</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=SCAR-Fc&amp;action=edit&amp;section=3\" title=\"Edit section: Discussion\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>Administration of sCAR-Fc beyond three days after initial exposure to the virus does not have any beneficial effects as cardiac damage is too severe.<sup id=\"cite_ref-c_2-2\" class=\"reference\"><a href=\"#cite_note-c-2\">&#91;2&#93;</a></sup> As such, the use of sCAR-Fc is currently limited to prophylactic treatments.\n</p>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=SCAR-Fc&amp;action=edit&amp;section=4\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist columns references-column-width\" style=\"-moz-column-width: 33em; -webkit-column-width: 33em; column-width: 33em; list-style-type: decimal;\">\n<ol class=\"references\">\n<li id=\"cite_note-a-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-a_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-a_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-a_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-a_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-a_1-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Werk D, Pinkert S, Heim A,  et al. (September 2009). \"Combination of soluble coxsackievirus-adenovirus receptor and anti-coxsackievirus siRNAs exerts synergistic antiviral activity against coxsackievirus B3\". <i>Antiviral Res</i>. <b>83</b> (3): 298\u2013306. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1016/j.antiviral.2009.07.002\">10.1016/j.antiviral.2009.07.002</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/19591879\">19591879</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Antiviral+Res.&amp;rft.atitle=Combination+of+soluble+coxsackievirus-adenovirus+receptor+and+anti-coxsackievirus+siRNAs+exerts+synergistic+antiviral+activity+against+coxsackievirus+B3&amp;rft.volume=83&amp;rft.issue=3&amp;rft.pages=298-306&amp;rft.date=2009-09&amp;rft_id=info%3Adoi%2F10.1016%2Fj.antiviral.2009.07.002&amp;rft_id=info%3Apmid%2F19591879&amp;rft.aulast=Werk&amp;rft.aufirst=D&amp;rft.au=Pinkert%2C+S&amp;rft.au=Heim%2C+A&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASCAR-Fc\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-c-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-c_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-c_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-c_2-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Goodfellow IG, Evans DJ, Blom AM,  et al. (September 2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1212587\">\"Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors\"</a>. <i>J. Virol</i>. <b>79</b> (18): 12016\u201324. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1128/JVI.79.18.12016-12024.2005\">10.1128/JVI.79.18.12016-12024.2005</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1212587\">1212587</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/16140777\">16140777</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Virol.&amp;rft.atitle=Inhibition+of+coxsackie+B+virus+infection+by+soluble+forms+of+its+receptors%3A+binding+affinities%2C+altered+particle+formation%2C+and+competition+with+cellular+receptors&amp;rft.volume=79&amp;rft.issue=18&amp;rft.pages=12016-24&amp;rft.date=2005-09&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1212587&amp;rft_id=info%3Apmid%2F16140777&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.79.18.12016-12024.2005&amp;rft.aulast=Goodfellow&amp;rft.aufirst=IG&amp;rft.au=Evans%2C+DJ&amp;rft.au=Blom%2C+AM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1212587&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASCAR-Fc\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Yanagawa B, Spiller OB, Proctor DG,  et al. (April 2004). <a rel=\"nofollow\" class=\"external text\" href=\"http://jid.oxfordjournals.org/content/189/8/1431.long\">\"Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice\"</a>. <i>J. Infect. Dis</i>. <b>189</b> (8): 1431\u20139. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1086/382598\">10.1086/382598</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15073680\">15073680</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Infect.+Dis.&amp;rft.atitle=Soluble+recombinant+coxsackievirus+and+adenovirus+receptor+abrogates+coxsackievirus+b3-mediated+pancreatitis+and+myocarditis+in+mice&amp;rft.volume=189&amp;rft.issue=8&amp;rft.pages=1431-9&amp;rft.date=2004-04&amp;rft_id=info%3Adoi%2F10.1086%2F382598&amp;rft_id=info%3Apmid%2F15073680&amp;rft.aulast=Yanagawa&amp;rft.aufirst=B&amp;rft.au=Spiller%2C+OB&amp;rft.au=Proctor%2C+DG&amp;rft_id=http%3A%2F%2Fjid.oxfordjournals.org%2Fcontent%2F189%2F8%2F1431.long&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASCAR-Fc\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Woodruff JF (November 1980). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1903609\">\"Viral myocarditis. A review\"</a>. <i>Am. J. Pathol</i>. <b>101</b> (2): 425\u201384. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC1903609\">1903609</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/6254364\">6254364</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am.+J.+Pathol.&amp;rft.atitle=Viral+myocarditis.+A+review&amp;rft.volume=101&amp;rft.issue=2&amp;rft.pages=425-84&amp;rft.date=1980-11&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1903609&amp;rft_id=info%3Apmid%2F6254364&amp;rft.au=Woodruff+JF&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC1903609&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASCAR-Fc\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-b-5\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-b_5-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-b_5-1\"><sup><i><b>b</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Onyimba JA, Coronado MJ, Garton AE,  et al. (2011). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3049118\">\"The innate immune response to coxsackievirus B3 predicts progression to cardiovascular disease and heart failure in male mice\"</a>. <i>Biol Sex Differ</i>. <b>2</b>: 2. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1186/2042-6410-2-2\">10.1186/2042-6410-2-2</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC3049118\">3049118</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21338512\">21338512</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Biol+Sex+Differ&amp;rft.atitle=The+innate+immune+response+to+coxsackievirus+B3+predicts+progression+to+cardiovascular+disease+and+heart+failure+in+male+mice&amp;rft.volume=2&amp;rft.pages=2&amp;rft.date=2011&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3049118&amp;rft_id=info%3Apmid%2F21338512&amp;rft_id=info%3Adoi%2F10.1186%2F2042-6410-2-2&amp;rft.aulast=Onyimba&amp;rft.aufirst=JA&amp;rft.au=Coronado%2C+MJ&amp;rft.au=Garton%2C+AE&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3049118&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASCAR-Fc\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-6\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-6\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Herzum M, Ruppert V, K\u00fcytz B, Jomaa H, Nakamura I, Maisch B (July 1994). \"Coxsackievirus B3 infection leads to cell death of cardiac myocytes\". <i>J. Mol. Cell. Cardiol</i>. <b>26</b> (7): 907\u201313. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1006/jmcc.1994.1108\">10.1006/jmcc.1994.1108</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/7966359\">7966359</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Mol.+Cell.+Cardiol.&amp;rft.atitle=Coxsackievirus+B3+infection+leads+to+cell+death+of+cardiac+myocytes&amp;rft.volume=26&amp;rft.issue=7&amp;rft.pages=907-13&amp;rft.date=1994-07&amp;rft_id=info%3Adoi%2F10.1006%2Fjmcc.1994.1108&amp;rft_id=info%3Apmid%2F7966359&amp;rft.aulast=Herzum&amp;rft.aufirst=M&amp;rft.au=Ruppert%2C+V&amp;rft.au=K%C3%BCytz%2C+B&amp;rft.au=Jomaa%2C+H&amp;rft.au=Nakamura%2C+I&amp;rft.au=Maisch%2C+B&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASCAR-Fc\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Fechner H, Pinkert S, Geisler A, Poller W, Kurreck J (2011). \"Pharmacological and biological antiviral therapeutics for cardiac coxsackievirus infections\". <i>Molecules</i>. <b>16</b> (10): 8475\u2013503. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.3390/molecules16108475\">10.3390/molecules16108475</a>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/21989310\">21989310</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Molecules&amp;rft.atitle=Pharmacological+and+biological+antiviral+therapeutics+for+cardiac+coxsackievirus+infections&amp;rft.volume=16&amp;rft.issue=10&amp;rft.pages=8475-503&amp;rft.date=2011&amp;rft_id=info%3Adoi%2F10.3390%2Fmolecules16108475&amp;rft_id=info%3Apmid%2F21989310&amp;rft.aulast=Fechner&amp;rft.aufirst=H&amp;rft.au=Pinkert%2C+S&amp;rft.au=Geisler%2C+A&amp;rft.au=Poller%2C+W&amp;rft.au=Kurreck%2C+J&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASCAR-Fc\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><cite class=\"citation journal\">Milstone AM, Petrella J, Sanchez MD, Mahmud M, Whitbeck JC, Bergelson JM (January 2005). <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC538729\">\"Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate\"</a>. <i>J. Virol</i>. <b>79</b> (1): 655\u201360. <a href=\"/wiki/Digital_object_identifier\" title=\"Digital object identifier\">doi</a>:<a rel=\"nofollow\" class=\"external text\" href=\"//doi.org/10.1128/JVI.79.1.655-660.2005\">10.1128/JVI.79.1.655-660.2005</a>. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC538729\">538729</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/15596863\">15596863</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=J.+Virol.&amp;rft.atitle=Interaction+with+coxsackievirus+and+adenovirus+receptor%2C+but+not+with+decay-accelerating+factor+%28DAF%29%2C+induces+A-particle+formation+in+a+DAF-binding+coxsackievirus+B3+isolate&amp;rft.volume=79&amp;rft.issue=1&amp;rft.pages=655-60&amp;rft.date=2005-01&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC538729&amp;rft_id=info%3Apmid%2F15596863&amp;rft_id=info%3Adoi%2F10.1128%2FJVI.79.1.655-660.2005&amp;rft.aulast=Milstone&amp;rft.aufirst=AM&amp;rft.au=Petrella%2C+J&amp;rft.au=Sanchez%2C+MD&amp;rft.au=Mahmud%2C+M&amp;rft.au=Whitbeck%2C+JC&amp;rft.au=Bergelson%2C+JM&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC538729&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3ASCAR-Fc\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n</ol></div>\n\n<!-- \nNewPP limit report\nParsed by mw2138\nCached time: 20180920164426\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.412 seconds\nReal time usage: 0.497 seconds\nPreprocessor visited node count: 626/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 21149/2097152 bytes\nTemplate argument size: 99/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 0/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 15570/5000000 bytes\nNumber of Wikibase entities loaded: 1/400\nLua time usage: 0.201/10.000 seconds\nLua memory usage: 2.91 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  437.658      1 -total\n 53.78%  235.380      1 Template:Reflist\n 41.41%  181.223      8 Template:Cite_journal\n 39.79%  174.137      1 Template:Infobox_medical_intervention\n 34.85%  152.544      1 Template:Infobox\n  2.12%    9.275      1 Template:PAGENAMEBASE\n  0.93%    4.067      1 Template:Template_other\n  0.75%    3.289      1 Template:Main_other\n  0.58%    2.524      1 Template:Column-width\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:35143854-0!canonical and timestamp 20180920164425 and revision id 853098734\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","*":"Therapy"},{"sortkey":"","*":"Heart_diseases"},{"sortkey":"","*":"Medical_treatments"}],"links":[{"ns":0,"exists":"","*":"Capsid"},{"ns":0,"exists":"","*":"Cardiac dysrhythmias"},{"ns":0,"exists":"","*":"Coxsackie virus and adenovirus receptor"},{"ns":0,"exists":"","*":"Coxsackievirus"},{"ns":0,"exists":"","*":"Digital object identifier"},{"ns":0,"exists":"","*":"Dilated cardiomyopathy"},{"ns":0,"exists":"","*":"Ejection fraction"},{"ns":0,"exists":"","*":"Enterovirus"},{"ns":0,"exists":"","*":"Half-life"},{"ns":0,"exists":"","*":"IgG1"},{"ns":0,"exists":"","*":"Immunoglobulin"},{"ns":0,"exists":"","*":"Macrophages"},{"ns":0,"exists":"","*":"Myocarditis"},{"ns":0,"exists":"","*":"Myocyte"},{"ns":0,"exists":"","*":"Natural killer cells"},{"ns":0,"exists":"","*":"Necrosis"},{"ns":0,"exists":"","*":"Picornavirus"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"T cells"},{"ns":0,"exists":"","*":"Tight junction"},{"ns":0,"exists":"","*":"Tumor necrosis factor-alpha"}],"templates":[{"ns":10,"exists":"","*":"Template:Infobox medical intervention"},{"ns":10,"exists":"","*":"Template:Infobox"},{"ns":10,"exists":"","*":"Template:PAGENAMEBASE"},{"ns":10,"exists":"","*":"Template:Template other"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Column-width"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":828,"exists":"","*":"Module:Infobox"},{"ns":828,"exists":"","*":"Module:Navbar"},{"ns":828,"exists":"","*":"Module:String"},{"ns":828,"exists":"","*":"Module:InfoboxImage"},{"ns":828,"exists":"","*":"Module:Wikidata"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:I18n"},{"ns":828,"*":"Module:Infobox/i18n"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"}],"images":["Lock-green.svg"],"externallinks":["//doi.org/10.1016/j.antiviral.2009.07.002","//www.ncbi.nlm.nih.gov/pubmed/19591879","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1212587","//doi.org/10.1128/JVI.79.18.12016-12024.2005","//www.ncbi.nlm.nih.gov/pubmed/16140777","http://jid.oxfordjournals.org/content/189/8/1431.long","//doi.org/10.1086/382598","//www.ncbi.nlm.nih.gov/pubmed/15073680","//www.ncbi.nlm.nih.gov/pmc/articles/PMC1903609","//www.ncbi.nlm.nih.gov/pubmed/6254364","//www.ncbi.nlm.nih.gov/pmc/articles/PMC3049118","//doi.org/10.1186/2042-6410-2-2","//www.ncbi.nlm.nih.gov/pubmed/21338512","//doi.org/10.1006/jmcc.1994.1108","//www.ncbi.nlm.nih.gov/pubmed/7966359","//doi.org/10.3390/molecules16108475","//www.ncbi.nlm.nih.gov/pubmed/21989310","//www.ncbi.nlm.nih.gov/pmc/articles/PMC538729","//doi.org/10.1128/JVI.79.1.655-660.2005","//www.ncbi.nlm.nih.gov/pubmed/15596863"],"sections":[{"toclevel":1,"level":"2","line":"Myocarditis","number":"1","index":"1","fromtitle":"SCAR-Fc","byteoffset":1266,"anchor":"Myocarditis"},{"toclevel":1,"level":"2","line":"Mechanism","number":"2","index":"2","fromtitle":"SCAR-Fc","byteoffset":5087,"anchor":"Mechanism"},{"toclevel":1,"level":"2","line":"Discussion","number":"3","index":"3","fromtitle":"SCAR-Fc","byteoffset":6898,"anchor":"Discussion"},{"toclevel":1,"level":"2","line":"References","number":"4","index":"4","fromtitle":"SCAR-Fc","byteoffset":7157,"anchor":"References"}],"parsewarnings":[],"displaytitle":"SCAR-Fc","iwlinks":[{"prefix":"d","url":"https://www.wikidata.org/wiki/Q7389070","*":"d:Q7389070"}],"properties":[{"name":"wikibase_item","*":"Q7389070"}]}}